Table 2.

Antimicrobial Peptide Names and Corresponding Sequences Discussed in the Review.

Sl. No	Peptide Name	Peptide Sequence	Reference	Clinical Tril ID (If Available) *
1	HNP-1	ACYCRIPACIAGERRYGTCIYQGRLWAFCC	[48]
2	Drosocin	GKPRPYSPRPTSHPRPIRV	[49]
3	Melittin	GIGAVLKVLTTGLPALISWIKRKRQQ	[47]	NCT02364349
4	LL-37	LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	[15]	NCT02225366
5	HBD-2	GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP	[16]
6	HBD-3	GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKK	[16]
7	Protegrin-1	RGGRLCYCRRRFCVCVGR	[17]
8	Ranalexin	FLGGLIKIVPAMICAVTKKC	[19]
9	Pexiganan	GIGKFLKKAKKFGKAFVKILKK	[20]	NCT01594762
10	α-MSH	SYSMEHFRWGKPV	[23]
11	Melimine	TLISWIKNKRKQRPRVSRRRRRRGGRRRR	[24]
12	Magainin 2	GIGKFLHSAKKFGKAFVGEIMNS	[21]	NCT00563433
13	Dermcidin	SSLLEKGLDGAKKAVGGLGKLGKDAVEDLESVGKGAVHDVKDVLDSV	[27]
14	Dermaceptin	ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ	[29]
15	Nisin A	ITSISLCTPGCKTGALMGCNMKTATCHCSIHVSK	[36]	NCT02928042
16	Omiganan (Indolicidin derivative)	ILRWPWWPWRRK	[50,51]	NCT03071679
17	HBD-1	DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK	[31]
18	HBD-5	GLDFSQPFPSGEFAVCESCKLGRGKCRKECLENEKPDGNCRLNFLCCRQRI	[52]
19	Cateslytin	RSMRLSFRARGYGFR	[33]
20	GH-12	GLLWHLLHHLLH	[53]
21	Myxinidin	GIHDILKYGKPS	[54]
22	HHC-36	KRWWKWWRR	[55]
23	KLD-12	KLDLKLDLKLDL	[35]
24	E14LKK	LKLLKKLLKLLKKL	[56]
25	Dermaseptin-S4	ALWMTLLKKVLKAAAKAALNAVLVGANA	[57]
26	Ib-AMP4	QWGRRCCGWGPGRRYCRRWC
27	LLKKK18	KEFKRIVKRIKKFLRKLV	[39]
28	DPK-060	GKHKNKGKKNGKHNGWKWWW	[40]	NCT01522391
29	SMAP-29	RGLRRLGRKIAHGVKKYGPTVLRIIRIAG	[37]
30	MSI-78	GIGKFLKKAKKFGKAFVKILKK		NCT00563394
31	Bac2A	RLCRIVVIRVCR	[58]
32	Chain201D	KWIVWRWRFKR	[59]
33	E6	RRWRIVVIRVRRC	[60]
34	Yao et al. (Unnamed Peptide)	(RWRWRWC–NH2)	[61]
35	SESB2V	[(RGRKVVRR)2K]2KK	[62]
36	Temporin-1CEa	FVDLKKIANIINSIF	[63]
37	Esc(1–21)	GIFSKLAGKKIKNLLISGLKG-NH2	[64]
38	18-mer LLKKK	KLFKRIVKRILKFLRKLV	[65]
39	Thanatin	GSKKPVPIIYCNRRTGKCQRM	[38]
40	Histatins	Sequence Differs Across Subtypes With Conserved Cationic Nature	[18,30]
41	BmKn2	FIGAIARLLSKIFGKR	[66]
42	Microcin E492	GETDPNTQLLNDLGNNMAWGAALGAPGGLGSAALGAAGGALQTVGQGLIDHGPVNVFIPVLIGPSWNGSGSGYNSATSSSGSGS	[67]
43	BR2	RAGLQFPVGRLLRRLLR	[68]
44	pAntp	RQIKIWFQNRRMKWKK	[69]
45	pTAT	RKKRRQRRR	[70]
46	KT2	NGVQPKYKWWKWWKKWW	[44]
47	RT2	NGVQPKYRWWRWWRRWW	[45]
48	LTX-315	KKWWKKWDip ** K	[71]	NCT04796194

* Source: Clinicaltrials.gov. ** Dip is β-diphenylalanine.